Cargando…
INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer
BACKGROUND: Inhibin subunit beta B (INHBB) is a protein-coding gene that participated in the synthesis of the transforming growth factor-β (TGF-β) family members. The study is aimed at exploring the clinical significance of INHBB in patients with colorectal cancer (CRC) by bioinformatics analysis. M...
Autores principales: | Yuan, Jinpeng, Xie, Aosi, Cao, Qiangjian, Li, Xinxin, Chen, Juntian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563060/ https://www.ncbi.nlm.nih.gov/pubmed/33083477 http://dx.doi.org/10.1155/2020/6909672 |
Ejemplares similares
-
Differences in oncological outcomes and inflammatory biomarkers between right‐sided and left‐sided stage I‐III colorectal adenocarcinoma
por: Guo, Dongming, et al.
Publicado: (2019) -
INHBB is a novel prognostic biomarker and correlated with immune infiltrates in gastric cancer
por: Yu, Weifeng, et al.
Publicado: (2022) -
Diagnostic performance of circulating exosomes in human cancer: A meta‐analysis
por: Guo, Dongming, et al.
Publicado: (2020) -
Prognostic and diagnostic value of circRNA expression in colorectal carcinoma: a meta-analysis
por: Yuan, Jinpeng, et al.
Publicado: (2020) -
Clinical correlations and prognostic value of Nudix hydroxylase 10 in patients with gastric cancer
por: Chen, Diqun, et al.
Publicado: (2021)